influential [idcn]
Age [orga]
Gender [orga]
Race [popg]
Efficacy [qlco]
ADD [mobd]
ezetimibe [orch, phsu]
atorvastatin [orch, phsu]
atorvastatin [orch, phsu]
Titration [lbpr]
Patients [podg]
Moderately [qlco]
High Risk [qlco]
coronary heart disease [dsyn]
Age [orga]
Gender [orga]
Race [popg]
atherosclerotic [ftcn]
Coronary heart disease risk [inpr]
Affect [menp]
Efficacy [qlco]
Lipid [lipd]
Altered [ftcn]
Drugs [phsu]
Methods [inpr]
Post [tmco]
DOUBLE BLIND [resa]
randomized [resa]
Parallel [qlco]
Group [idcn]
Trial [resa]
Assessed [acty]
Age [orga]
Gender [orga]
Race [popg]
White [popg]
Black [popg]
effects [qlco]
ATORVASTATIN/EZETIMIBE [phsu]
Plus [qlco]
Titration [lbpr]
atorvastatin [orch, phsu]
Patients [podg]
Coronary heart disease risk [inpr]
Coronary heart disease risk [inpr]
Subject [grup]
Low density lipoprotein [aapp, bacs, lipd]
cholesterol levels [lbpr]
mg dl [qnco]
Stable [qlco]
atorvastatin 40 MG [clnd]
therapy [ftcn]
randomized [resa]
atorvastatin [orch, phsu]
mg/mg [qnco]
Plus [qlco]
ezetimibe [orch, phsu]
Titrate [hlca]
atorvastatin 80 MG [clnd]
Moderately [qlco]
Coronary heart disease risk [inpr]
Subject [grup]
Cholesterol, LDL [bacs, strd]
mg dl [qnco]
atorvastatin 20 MG [clnd]
randomized [resa]
atorvastatin [orch, phsu]
mg/mg [qnco]
Plus [qlco]
ezetimibe [orch, phsu]
atorvastatin 40 MG [clnd]
Variability [cnce]
Exist [cnce]
Age [orga]
Gender [orga]
Race [popg]
subgroups [virs]
Entire [qnco]
Lipid [lipd]
Altered [ftcn]
findings [ftcn]
ezetimibe [orch, phsu]
atorvastatin [orch, phsu]
Percent [qnco]
reductions [npop]
Cholesterol, LDL [bacs, strd]
Total Cholesterol [lbpr]
Triglycerides [bacs, lipd]
High Density Lipoprotein Cholesterol [bacs, lipd]
Apolipoprotein B [aapp, bacs]
Titration [lbpr]
atorvastatin [orch, phsu]
subgroups [virs]
High Density Lipoprotein Cholesterol [bacs, lipd]
Apolipoprotein AI [aapp, bacs]
Small [qnco]
Variable [qlco]
Treatment Efficacy [qlco]
Age [orga]
Gender [orga]
Race [popg]
subgroups [virs]
Entire [qnco]
Study Population [popg]
ezetimibe [orch, phsu]
Combined [qlco]
atorvastatin [orch, phsu]
Incremental [qnco]
reductions [npop]
Cholesterol, LDL [bacs, strd]
Several [qnco]
Lipid [lipd]
Parameters [fndg]
Compared [acty]
doubling [ftcn]
atorvastatin [orch, phsu]
Dose [qnco]
Patients [podg]
Moderately [qlco]
Coronary heart disease risk [inpr]
Suggest [idcn]
Administration [ocac]
ezetimibe [orch, phsu]
Statins [orch, phsu]
Therapeutic [topp]
Option [ftcn]
treatment [ftcn]
Dyslipidaemia [dsyn]
Ireland [geoa]
LTD [ortf]
Reserve [acty]
